These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28730840)

  • 41. Emergency contraception: separating fact from fiction.
    Batur P
    Cleve Clin J Med; 2012 Nov; 79(11):771-6. PubMed ID: 23125326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study.
    Envall N; Groes Kofoed N; Kopp-Kallner H
    Acta Obstet Gynecol Scand; 2016 Aug; 95(8):887-93. PubMed ID: 27109900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developments and challenges in emergency contraception.
    Black KI
    Best Pract Res Clin Obstet Gynaecol; 2009 Apr; 23(2):221-31. PubMed ID: 19211308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An emergency contraception algorithm based on risk assessment: changes in clinicians' practice and patients' choices.
    McKay RJ; Gilbert L
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):201-6. PubMed ID: 23430815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
    Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
    Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interventions for emergency contraception.
    Cheng L; Gülmezoglu AM; Oel CJ; Piaggio G; Ezcurra E; Look PF
    Cochrane Database Syst Rev; 2004; (3):CD001324. PubMed ID: 15266446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ulipristal acetate for emergency contraception.
    Russo JA; Creinin MD
    Drugs Today (Barc); 2010 Sep; 46(9):655-60. PubMed ID: 20967297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergency contraception: an underutilized resource.
    Dalby J; Hayon R; Paddock E; Schrager S
    J Fam Pract; 2012 Jul; 61(7):392-7. PubMed ID: 22754889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventions for emergency contraception.
    Cheng L; Gülmezoglu AM; Piaggio G; Ezcurra E; Van Look PF
    Cochrane Database Syst Rev; 2008 Apr; (2):CD001324. PubMed ID: 18425871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The rationale for use of Ulipristal Acetate as first line in emergency contraception: biological and clinical evidence.
    Glasier A
    Gynecol Endocrinol; 2014 Oct; 30(10):688-90. PubMed ID: 25133564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levonorgestrel emergency contraception and bodyweight.
    Kardos L; Magyar G; Schváb E; Luczai E
    Curr Med Res Opin; 2019 Jul; 35(7):1149-1155. PubMed ID: 30569769
    [No Abstract]   [Full Text] [Related]  

  • 53. Ulipristal acetate: the newest emergency contraceptive.
    Wilton JM
    Nurs Womens Health; 2012; 16(4):331-5. PubMed ID: 22900810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EC4U: results from a pilot project integrating the copper IUC into emergency contraceptive care.
    Kohn JE; Nucatola DL
    Contraception; 2016 Jul; 94(1):48-51. PubMed ID: 26877186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel.
    Glasier A; Cameron ST; Blithe D; Scherrer B; Mathe H; Levy D; Gainer E; Ulmann A
    Contraception; 2011 Oct; 84(4):363-7. PubMed ID: 21920190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of ulipristal acetate and levonorgestrel for emergency contraception: a follow-up study.
    Baird AS; Trussell J; Webb A
    J Fam Plann Reprod Health Care; 2015 Apr; 41(2):116-21. PubMed ID: 24869461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
    Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
    Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception.
    Turok DK; Gurtcheff SE; Handley E; Simonsen SE; Sok C; Murphy P
    Contraception; 2010 Dec; 82(6):520-5. PubMed ID: 21074014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of emergency contraception options over 1 year.
    Bellows BK; Tak CR; Sanders JN; Turok DK; Schwarz EB
    Am J Obstet Gynecol; 2018 May; 218(5):508.e1-508.e9. PubMed ID: 29409847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergency contraception: a survey of 1773 women.
    Bastianelli C; Rosato E; Farris M; Benagiano G
    Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):455-461. PubMed ID: 27684583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.